180 related articles for article (PubMed ID: 16546603)
1. Eosinophilic pustular folliculitis induced by chemotherapy.
Laing ME; Laing TA; Mulligan NJ; Keane FM
J Am Acad Dermatol; 2006 Apr; 54(4):729-30. PubMed ID: 16546603
[No Abstract] [Full Text] [Related]
2. [Secondary effects of adjuvant therapy].
Giai M; De Fabiani E; Lamberto A; Cortese P; Giardina G
Minerva Ginecol; 1985 Jun; 37(6):319-28. PubMed ID: 3162112
[No Abstract] [Full Text] [Related]
3. Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab.
Black JM; Hodari KT; Rogers N; Farris PK; Lewis AT; Boh EE
Arch Dermatol; 2011 Jan; 147(1):134-5. PubMed ID: 21242416
[No Abstract] [Full Text] [Related]
4. Eosinophilic pustular folliculitis induced by carbamazepine.
Mizoguchi S; Setoyama M; Higashi Y; Hozumi H; Kanzaki T
J Am Acad Dermatol; 1998 Apr; 38(4):641-3. PubMed ID: 9555813
[No Abstract] [Full Text] [Related]
5. Eosinophilic cellulitis and eosinophilic pustular folliculitis.
Andreano JM; Kantor GR; Bergfeld WF; Tuthill RJ; Taylor JS
J Am Acad Dermatol; 1989 May; 20(5 Pt 2):934-6. PubMed ID: 2523914
[TBL] [Abstract][Full Text] [Related]
6. [Side effects of combined antineoplastic chemotherapy on hemostasis in patients with breast cancer].
Pinto Pedrazzi AH; de Souza AM
Rev Fac Farm Odontol Ribeiro Preto; 1982; 19(1):29-41. PubMed ID: 6964932
[No Abstract] [Full Text] [Related]
7. Potential risk of a common hereditary thrombophilia and adjuvant chemotherapy for low-stage breast cancer.
Ely SF
J Clin Oncol; 2005 Jun; 23(18):4242-3. PubMed ID: 15961781
[No Abstract] [Full Text] [Related]
8. Calling attention to radiation recall reactions. Simultaneous occurrence of a Recall Dermatitis after CMF application in two separate sites irradiated 10 years apart.
Partl R; Richtig E; Kapp KS
Acta Oncol; 2012 Jul; 51(6):809-11. PubMed ID: 22175251
[No Abstract] [Full Text] [Related]
9. Recall of UVB-induced erythema in breast cancer patient receiving multiple drug chemotherapy.
Andersen KE; Lindskov R
Photodermatol; 1984 Jun; 1(3):129-32. PubMed ID: 6527953
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced scleroderma: a pleiomorphic syndrome.
Alexandrescu DT; Bhagwati NS; Wiernik PH
Clin Exp Dermatol; 2005 Mar; 30(2):141-5. PubMed ID: 15725240
[TBL] [Abstract][Full Text] [Related]
11. A case of atypical eosinophilic pustular folliculitis that emerged following the administration of capecitabine.
Takeuchi A; Nomura T; Kaku Y; Egawa G; Kabashima K
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e317-e318. PubMed ID: 29444365
[No Abstract] [Full Text] [Related]
12. Case 6-1985: progressive pneumonitis after chemotherapy for breast cancer.
N Engl J Med; 1985 Jul; 313(1):49-50. PubMed ID: 3839046
[No Abstract] [Full Text] [Related]
13. In regards to Arcangeli et al. (Int J Radiat Oncol Biol Phys 2006;64:161-167).
Munshi A; Jalali R; Budrukar A
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):632; author reply 632-3. PubMed ID: 16690446
[No Abstract] [Full Text] [Related]
14. Intravesical mitomycin C-induced generalized pustular folliculitis.
Andreu-Barasoain M; Gómez de la Fuente E; Pinedo F; Nuño A; López-Estebaranz JL
J Am Acad Dermatol; 2012 Oct; 67(4):e142-3. PubMed ID: 22980268
[No Abstract] [Full Text] [Related]
15. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
Gül U; Kiliç A
Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
[No Abstract] [Full Text] [Related]
16. [Medical treatment of early breast cancer: chemotherapy].
Ejlertsen B; Kamby C
Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
[TBL] [Abstract][Full Text] [Related]
17. A case of eosinophilic pustular folliculitis (Ofuji's disease) induced by patch and challenge tests with indeloxazine hydrochloride.
Kimura K; Ezoe K; Yokozeki H; Katayama I; Nishioka K
J Dermatol; 1996 Jul; 23(7):479-83. PubMed ID: 8772029
[TBL] [Abstract][Full Text] [Related]
18. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus after antineoplastic chemotherapy.
Sartori S; Nielsen I; Trevisani L; Pazzi P; Malacarne P
Endoscopy; 1990 May; 22(3):152. PubMed ID: 2357940
[No Abstract] [Full Text] [Related]
20. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
